A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment

NCT05730218 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhegmatogenous Retinal Detachment - Macula Off

Interventions

DRUG: ONL1204 Ophthalmic Solution
DRUG: Sham treatment

Sponsor

ONL Therapeutics